Cytotoxic drugs for non-neoplastic disease.
作者信息
Ansell G, Evans S, Jackson C T, Lewis-Jones S
出版信息
Br Med J (Clin Res Ed). 1983 Sep 10;287(6394):762. doi: 10.1136/bmj.287.6394.762-a.
Abstract
摘要
相似文献
1
Cytotoxic drugs for non-neoplastic disease.用于非肿瘤性疾病的细胞毒性药物。
Br Med J (Clin Res Ed). 1983 Sep 10;287(6394):762. doi: 10.1136/bmj.287.6394.762-a.
2
Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission.急性白血病缓解期甲氨蝶呤治疗继发的骨质疏松性骨折
Cancer. 1970 Mar;25(3):580-5. doi: 10.1002/1097-0142(197003)25:3<580::aid-cncr2820250313>3.0.co;2-m.
3
Multiple stress fractures in a scleroderma patient on methotrexate therapy.
Rev Rhum Engl Ed. 1998 Jul-Sep;65(7-9):508-10.
4
Thyroxine, osteoporosis and fractures in the mentally handicapped.智障人群中的甲状腺素、骨质疏松症与骨折
West Engl Med J. 1990 Mar;105(1):25.
5
Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis.长期低剂量甲氨蝶呤治疗银屑病和类风湿关节炎中的甲氨蝶呤性骨病
Arch Dermatol. 1996 Feb;132(2):184-7.
6
[Osteoporosis, with pathological fracture and cataract, caused by chronic corticotherapy].[因长期皮质激素治疗导致的骨质疏松症，伴有病理性骨折和白内障]
Prensa Med Argent. 1972 Jun 16;59(20):786-7.
7
[Osteoporosis and fractures associated with drugs].[与药物相关的骨质疏松症和骨折]
Ugeskr Laeger. 2008 Apr 28;170(18):1550-5.
8
[Drugs with side effects affecting calcium homeostasis, bone metabolism and risk of fractures].[具有影响钙稳态、骨代谢及骨折风险副作用的药物]
Ugeskr Laeger. 2005 Feb 28;167(9):1026-30.
9
Water fluoride and fractures.水中氟化物与骨折
N Z Med J. 1991 Aug 14;104(917):343.
10
[Three patients with a fracture during methotrexate use, possibly due to methotrexate osteopathy].[3例患者在使用甲氨蝶呤期间发生骨折，可能系甲氨蝶呤性骨病所致]
Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2357-60.
引用本文的文献
1
Talus insufficiency fracture due to long-term methotrexate therapy in a patient with rheumatoid arthritis.一名类风湿关节炎患者因长期使用甲氨蝶呤治疗导致距骨不全骨折。
J Surg Case Rep. 2025 Oct 2;2025(10):rjaf780. doi: 10.1093/jscr/rjaf780. eCollection 2025 Oct.
2
METHOFRACT, a methotrexate osteopathy multicentre cohort study.甲氨蝶呤治疗骨病多中心队列研究（METHOFRACT）
RMD Open. 2025 Sep 25;11(3):e005941. doi: 10.1136/rmdopen-2025-005941.
3
Methotrexate osteopathy: Old description, but still important to know.甲氨蝶呤性骨病：旧有描述，但仍有必要了解。
ACR Open Rheumatol. 2025 Apr;7(4):e70039. doi: 10.1002/acr2.70039.
4
MTX Osteopathy Versus Osteoporosis Including Response to Treatment Data-A Retrospective Single Center Study Including 172 Patients.MTX 整骨疗法与骨质疏松症（包括治疗反应数据）——一项包括 172 例患者的回顾性单中心研究。
Calcif Tissue Int. 2024 Nov;115(5):599-610. doi: 10.1007/s00223-024-01290-5. Epub 2024 Sep 25.
本文引用的文献
1
Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission.急性白血病缓解期甲氨蝶呤治疗继发的骨质疏松性骨折
Cancer. 1970 Mar;25(3):580-5. doi: 10.1002/1097-0142(197003)25:3<580::aid-cncr2820250313>3.0.co;2-m.
2
Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems.甲氨蝶呤对肝脏、肺和骨骼系统的急性和慢性影响。
Cancer. 1976 Feb;37(2 Suppl):1048-57. doi: 10.1002/1097-0142(197602)37:2+<1048::aid-cncr2820370811>3.0.co;2-v.
3
Osteonecrosis after chemotherapy.化疗后骨坏死
Lancet. 1978 Jun 17;1(8077):1316. doi: 10.1016/s0140-6736(78)91306-5.
Zotero 插件